These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 31715081

  • 21. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD, Fu ZQ, Lin Q, Zhou Y, Zhou QB, Li ZH, Tan LP, Chen RF, Liu YM.
    World J Gastroenterol; 2015 Aug 21; 21(31):9348-57. PubMed ID: 26309360
    [Abstract] [Full Text] [Related]

  • 22. LncRNA PCAT6 promotes the proliferation, migration and invasion of pancreatic ductal adenocarcinoma via regulating miR-185-5p/CBX2 axis.
    Wang W, Li X, Guan C, Hu Z, Zhao Y, Li W, Jiang X.
    Pathol Res Pract; 2020 Sep 21; 216(9):153074. PubMed ID: 32825947
    [Abstract] [Full Text] [Related]

  • 23. Long non-coding RNA CUDR promotes malignant phenotypes in pancreatic ductal adenocarcinoma via activating AKT and ERK signaling pathways.
    Liang X, Qi M, Wu R, Liu A, Chen D, Tang L, Chen J, Hu X, Li W, Zhan L, Shao C.
    Int J Oncol; 2018 Dec 21; 53(6):2671-2682. PubMed ID: 30272271
    [Abstract] [Full Text] [Related]

  • 24. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer.
    Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H, Wang Y, Zeng J, Song Y, Gao W, Zheng S, Zhuang B, Chen H, Li W, Li H, Li H, Fu Z, Chen R.
    J Transl Med; 2015 Mar 12; 13():84. PubMed ID: 25889214
    [Abstract] [Full Text] [Related]

  • 25. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
    Meng F, Li W, Li C, Gao Z, Guo K, Song S.
    Int J Oncol; 2015 Mar 12; 46(3):1109-20. PubMed ID: 25502147
    [Abstract] [Full Text] [Related]

  • 26. H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT.
    Ma C, Nong K, Zhu H, Wang W, Huang X, Yuan Z, Ai K.
    Tumour Biol; 2014 Sep 12; 35(9):9163-9. PubMed ID: 24920070
    [Abstract] [Full Text] [Related]

  • 27. Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC.
    Cao XY, Zhang XX, Yang MW, Hu LP, Jiang SH, Tian GA, Zhu LL, Li Q, Sun YW, Zhang ZG.
    Biochem Biophys Res Commun; 2018 May 15; 499(3):584-593. PubMed ID: 29621546
    [Abstract] [Full Text] [Related]

  • 28. lncRNA THAP9-AS1 Promotes Pancreatic Ductal Adenocarcinoma Growth and Leads to a Poor Clinical Outcome via Sponging miR-484 and Interacting with YAP.
    Li N, Yang G, Luo L, Ling L, Wang X, Shi L, Lan J, Jia X, Zhang Q, Long Z, Liu J, Hu W, He Z, Liu H, Liu W, Zheng G.
    Clin Cancer Res; 2020 Apr 01; 26(7):1736-1748. PubMed ID: 31831555
    [Abstract] [Full Text] [Related]

  • 29. GATA6-AS1 suppresses epithelial-mesenchymal transition of pancreatic cancer under hypoxia through regulating SNAI1 mRNA stability.
    Zhou Y, Zhou X, Ben Q, Liu N, Wang J, Zhai Y, Bao Y, Zhou L.
    J Transl Med; 2023 Dec 06; 21(1):882. PubMed ID: 38057853
    [Abstract] [Full Text] [Related]

  • 30. CircRTN4 promotes pancreatic cancer progression through a novel CircRNA-miRNA-lncRNA pathway and stabilizing epithelial-mesenchymal transition protein.
    Wong CH, Lou UK, Fung FK, Tong JHM, Zhang CH, To KF, Chan SL, Chen Y.
    Mol Cancer; 2022 Jan 04; 21(1):10. PubMed ID: 34983537
    [Abstract] [Full Text] [Related]

  • 31. Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b.
    Yang H, Liu P, Zhang J, Peng X, Lu Z, Yu S, Meng Y, Tong WM, Chen J.
    Oncogene; 2016 Jul 14; 35(28):3647-57. PubMed ID: 26549028
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
    Sun Y, Zhu Q, Yang W, Shan Y, Yu Z, Zhang Q, Wu H.
    J Cell Biochem; 2019 Mar 14; 120(3):3874-3886. PubMed ID: 30474270
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W, Shan Z, Zhou X, Peng L, Zhi C, Chai J, Liu H, Yang J, Zhang Z.
    Cancer Biomark; 2018 Mar 14; 23(4):589-601. PubMed ID: 30475755
    [Abstract] [Full Text] [Related]

  • 37. A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosis in pancreatic cancer.
    Zhang P, Cao M, Zhang Y, Xu L, Meng F, Wu X, Xia T, Chen Q, Shi G, Wu P, Chen L, Lu Z, Yin J, Cai B, Cao S, Miao Y, Jiang K.
    J Cell Mol Med; 2020 Sep 14; 24(18):10898-10912. PubMed ID: 32770626
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K, Lin Q, Li L, Bai X, Chen X, Chen H, Kong R, Wang Y, Zhu H, He F, Xu Q, Liu L, Li M, Zhang S, Nagaoka K, Carlson R, Safran H, Charpentier K, Sun B, Wands J, Dong X.
    J Hematol Oncol; 2019 Dec 30; 12(1):144. PubMed ID: 31888763
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.